The counterfeit clampdown
pharmafile | June 27, 2008 | Feature | Manufacturing and Production |Â Â Europe, counterfeits, parallel tradeÂ
Related Content
Phoenix Labs acquires Kent Pharma
Phoenix Labs has acquired UK pharmaceutical distributor Kent Pharma from private equity firm Duke Street, …
EC approves combination treatment for kidney cancer
The European Commission (EC) has approved Ipsen’s Cabometyx in combination with Opdivo as a first-line …
Janssen’s esketamine nasal spray gets Europe approval for new indication
The European Commission (EC) has authorised the expanded use of Janssen’s Spravato (esketamine nasal spray), co-administered …
